Trials / Terminated
TerminatedNCT00912899
A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
A Phase I Open Label Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Cougar Biotechnology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 1 study to evaluate the safety and determine maximum tolerated dose, safety \& tolerability of noscapine HCl in patients with advanced multiple myeloma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Noscapine HCl | Escalating doses given twice per day |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-06-03
- Last updated
- 2016-10-07
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00912899. Inclusion in this directory is not an endorsement.